acebutolol has been researched along with Hypertension, Malignant in 1 studies
Acebutolol: A cardioselective beta-1 adrenergic antagonist with little effect on the bronchial receptors. The drug has stabilizing and quinidine-like effects on cardiac rhythm, as well as weak inherent sympathomimetic action.
acebutolol : An ether that is the 2-acetyl-4-(butanoylamino)phenyl ether of the primary hydroxy group of 3-(propan-2-ylamino)propane-1,2-diol.
Hypertension, Malignant: A condition of markedly elevated BLOOD PRESSURE with DIASTOLIC PRESSURE usually greater than 120 mm Hg. Malignant hypertension is characterized by widespread vascular damage, PAPILLEDEMA, retinopathy, HYPERTENSIVE ENCEPHALOPATHY, and renal dysfunction.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The mean dosage of acebutolol was 10 mg/kg (maximum 22 mg/kg) and the drug was very well tolerated." | 6.64 | [Acebutolol in the treatment of arterial hypertension. Clinical study]. ( Chaignon, M; Guédon, J; Lucsko, M, 1975) |
| " The mean dosage of acebutolol was 10 mg/kg (maximum 22 mg/kg) and the drug was very well tolerated." | 2.64 | [Acebutolol in the treatment of arterial hypertension. Clinical study]. ( Chaignon, M; Guédon, J; Lucsko, M, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lucsko, M | 1 |
| Chaignon, M | 1 |
| Guédon, J | 1 |
1 trial available for acebutolol and Hypertension, Malignant
| Article | Year |
|---|---|
[Acebutolol in the treatment of arterial hypertension. Clinical study].
Topics: Acebutolol; Adolescent; Adult; Aged; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combin | 1975 |